iBio (IBIO) Enterprise Value (2010 - 2026)
iBio's (IBIO) quarterly Enterprise Value came in at -$74.8 million in Q1 2026, down 1396.36% year-on-year from $5.8 million in Q1 2025, and down 42.0% on a QoQ basis from -$52.7 million in Q4 2025.
iBio (IBIO) Enterprise Value (2010 - 2026) Analysis & Trends
iBio (IBIO) has 17 years of Enterprise Value data on file, last reported at -$74.8 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 1396.36% year-over-year to -$74.8 million in Q1 2026; TTM through Mar 2026 was -$74.8 million, a 1396.36% decrease from a year earlier, with the FY2025 full-year figure at -$8.6 million, up 39.61% from the prior year.
- Enterprise Value for Q1 2026 stood at -$74.8 million, down from -$52.7 million in the prior quarter.
- Over the last five years, Enterprise Value for IBIO reached as high as -$3.8 million in Q4 2023 and fell as low as -$74.8 million in Q1 2026.
- Historically, Enterprise Value has averaged -$20.6 million across 5 years, with a median of -$8.6 million in 2025.
- Across the five-year window, Enterprise Value soared 87.22% in 2022 and plunged 1396.36% in 2026, its largest moves.
- Year by year, Enterprise Value stood at -$6.0 million in 2022, then surged by 35.46% to -$3.8 million in 2023, then sank by 82.44% to -$7.0 million in 2024, then sank by 651.08% to -$52.7 million in 2025, then plunged by 42.0% to -$74.8 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$74.8 million in Q1 2026, -$52.7 million in Q4 2025, and -$49.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | -74.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.82 Mn |
| Dec 31, 2025 | -52.69 Mn |
| Sep 30, 2025 | -49.61 Mn |
| Jun 30, 2025 | -8.58 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Dec 31, 2024 | -7.02 Mn |
| Sep 30, 2024 | -11.00 Mn |
| Jun 30, 2024 | -14.21 Mn |
| Mar 31, 2024 | -6.22 Mn |
| Dec 31, 2023 | -3.85 Mn |
| Sep 30, 2023 | -4.51 Mn |
| Jun 30, 2023 | -7.33 Mn |
| Mar 31, 2023 | -6.56 Mn |
| Dec 31, 2022 | -5.96 Mn |
| Sep 30, 2022 | -15.23 Mn |
| Jun 30, 2022 | -33.52 Mn |
| Mar 31, 2022 | -43.26 Mn |
| Dec 31, 2021 | -46.61 Mn |
| Sep 30, 2021 | -71.71 Mn |
| Jun 30, 2021 | -96.99 Mn |